Murine Anti-GD2 Monoclonal Antibody 3F8 Combined With Granulocyte-Macrophage Colony-Stimulating Factor and 13-Cis-Retinoic Acid in High-Risk Patients With Stage 4 Neuroblastoma in First Remission We ...
Generally, the randomization for phase II trials is between two regimens, tumor response is the end point of interest, and the goal is to determine whether one experimental regimen should be brought ...
• Randomly assigning patients in a clinical quality registry combines the features of a prospective randomized trial with a large-scale clinical registry • Registry-based trials are less selective and ...
You can use the PLAN procedure to design a completely randomized design. Suppose you have 12 experimental units, and want to assign one of two treatments to each unit. Use a DATA step to store the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results